myirislogo
15 August, 2018 17:15 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Stl 578.90 1.70
Sun Pharma 601.65 6.91
State Bank O 294.70 0.03
I T C 307.25 0.44
Icici Bank 332.30 2.17
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Strides Shasun Limited
Strides Shasun Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532531NSE:STARBloomberg:STR@INReuters:STAR.BO
Market Lot: 1Face Value: 10ISIN Demat: INE939A01011
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
02-JUL-18 Strides Shasun today announced that it's wholly owned subsidiary Strides Pharma Global has received final approval for Ibuprofen Tablets USP, 200 mg (OTC) from the United States Food & Drug Administration (US FDA). 02-JUL-18 Strides Shasun today announced that its wholly owned subsidiary Strides Pharma Global has received tentative approval for its Para IV filing of Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Strides Shasun receives USFDA tentative approval for Milnacipran Hydrochloride Tablets  -IRIS 02-Jul-18
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2017(9)31-Mar-2017(12)31-Mar-2016(12)
Net sales 14234.3020981.3020630.70
Other Income1415.501761.901417.34
Total Income15649.8022743.2022048.04
Cost of goods sold14506.1019475.3019222.06
OPBDIT1143.703267.902825.98
PAT592.901197.301610.69
Gross Block---
Equity capital--893.46
EPS (Rs.)---
DPS (Rs.)---
BV (Rs.)---
P/E range (x)---
Debt / Equity (x)---
Operating margin (% of OI) 7.314.412.8
Net margin (% of OI) 3.8 5.3 7.3
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
No 201, Devavrata
Sector 17
Vashi
Navi Mumbai
Maharashtra-400 705
PHONE
(022) 2789 3199/ 5247
FAX
(022) 2789 2924/ 42
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer